| Literature DB >> 21925001 |
Abstract
Autoimmune blistering diseases (AIBD) often require high-dose corticosteroids and immunosuppressive agents for adequate control. These diseases cause significant morbidity but treatment can also lead to side effects and complications. This article reviews the supportive management of AIBD and the management of corticosteroid-induced side effects. The prevention and management of secondary effects from some of the more commonly used steroid-sparing agents for AIBD are summarized. Clinicians must be familiar with this information to optimally manage patients with AIBD.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21925001 DOI: 10.1016/j.det.2011.06.005
Source DB: PubMed Journal: Dermatol Clin ISSN: 0733-8635 Impact factor: 3.478